The Biliary HCO3 − Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies

Beuers, Ulrich, Hohenester, Simon, de Buy Wenniger, Lucas J. Maillette, Kremer, Andreas E., Jansen, Peter L. M., Elferink, Ronald P. J. Oude·2010·Hepatology
DOI 10.1002/hep.23810

Cited by (350)

Items 101–200 of 350

  1. IgG4-related cholangitis – a mimicker of fibrosing and malignant cholangiopathies
    Remco Kersten, David C. Trampert, Toni Herta, Lowiek M. Hubers, Lucas J. Maillette de Buy Wenniger, Joanne Verheij, Stan F.J. van de Graaf, Ulrich H. Beuers · 2023 · Journal of Hepatology
  2. Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders
    Michael A Trauner, Emina Halilbasic, Thierry Claudel, Daniel Steinacher, Claudia Daniela Fuchs, Tarek Moustafa, Marion Julia Pollheimer, Elisabeth Krones, Christian Kienbacher, Stefan Traussnigg et al. · 2015 · Digestive Diseases
  3. Primary biliary cholangitis: pathogenic mechanisms
    Jesús Prìeto, Jesús M. Bañales, Juan F. Medina · 2020 · Current Opinion in Gastroenterology
  4. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
    Ulrich H. Beuers, Eric M. Gershwin, Robert Gareth Gish, Pietro Invernizzi, David E. Jones, Keith D. Lindor, Xiong Ma, Ian R Mackay, Albert Rodrigo Parés, Atsushi Tanaka et al. · 2015 · The American Journal of Gastroenterology
  5. An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis
    Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma · 2018 · Laboratory Investigation
  6. Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis
    Marion Julia Pollheimer, Peter Fickert, Bruno Stieger · 2013 · Molecular Aspects of Medicine
  7. The history and future of bile acid therapies
    Ulrich H. Beuers, Jesús M. Bañales, Saul J. Karpen, Verena Keitel, Catherine Williamson, Michael Trauner · 2025 · Journal of Hepatology
  8. The Cholangiocyte Glycocalyx Stabilizes the ‘Biliary HCO3- Umbrella': An Integrated Line of Defense against Toxic Bile Acids
    Lucas J. Maillette de Buy Wenniger, Simon D. Hohenester, Luca Maroni, Sandra J. van Vliet, Ronald P.J. Oude Elferink, Ulrich H. Beuers · 2015 · Digestive Diseases
  9. Management of primary sclerosing cholangitis and its complications: an algorithmic approach
    Michal Prokopič, Ulrich H. Beuers · 2020 · Hepatology International
  10. TGR5 in cholangiocytes
    Verena Keitel, Dieter Häussinger · 2013 · Current Opinion in Gastroenterology
  11. Role of Bile Acids and the Biliary HCO3− Umbrella in the Pathogenesis of Primary Biliary Cholangitis
    Jorrit van Niekerk, Remco Kersten, Ulrich H. Beuers · 2018 · Clinics in Liver Disease
  12. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'
    Beuers, Ulrich, Gershwin, M. Eric, Gish, Robert G., Invernizzi, Pietro, Jones, David E.J., Lindor, Keith, Ma, Xiong, Mackay, Ian R., Parés, Albert, Tanaka, Atsushi et al. · 2015 · Clinics and Research in Hepatology and Gastroenterology
  13. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease
    Zakharia, Kais, Tabibian, Anilga, Lindor, Keith D., Tabibian, James H. · 2018 · Liver International
  14. Modifier genes in cystic fibrosis-related liver disease
    Dominique Debray, Harriet Corvol, Chantal Housset · 2018 · Current Opinion in Gastroenterology
  15. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes
    Lindsey Leann Kennedy, Guido Carpino, Travis M. Owen, Ludovica Ceci, Debjyoti Kundu, Vik Meadows, Konstantina Kyritsi, Antonio Franchitto, Paolo Onori, Abdulkadir Isidan et al. · 2022 · Journal of Hepatology
  16. A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.
    Fernanda Quadros Onofrio, Gideon Morris Hirschfield, Aliya F. Gulamhusein · 2019 · Europe PMC (PubMed Central)
  17. Ursodeoxycholic acid in pregnancy?
    de Vries, Elsemieke, Beuers, Ulrich · 2019 · Journal of Hepatology
  18. Impact of Machine Perfusion on Biliary Complications after Liver Transplantation
    Andrea A. Schlegel, Philipp Dutkowski · 2018 · International Journal of Molecular Sciences
  19. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products
    Yanling Zhao, Shizhang Wei, Lisheng Chen, Xuelin Zhou, Xiao Ma · 2023 · Frontiers in Immunology
  20. Central role for cholangiocyte pathobiology in cholestatic liver diseases
    Jalan-Sakrikar, Nidhi, Guicciardi, Maria Eugenia, O’Hara, Steven P., Azad, Adiba, LaRusso, Nicholas F., Gores, Gregory J., Huebert, Robert C. · 2025 · Hepatology
  21. Rescue of epithelial HCO3− secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del
    Fang Xiao, Junhua Li, Anurag Kumar Singh, Brigitte Riederer, Jiang Wang, Ayesha Sultan, Henry Park, Min Goo Lee, Georg Lamprecht, Bob J. Scholte et al. · 2012 · The Journal of Physiology
  22. Inflammation: Cause or consequence of chronic cholestatic liver injury
    Benjamin Leeland Woolbright · 2020 · Food and Chemical Toxicology
  23. Review article: pathophysiology and management of primary biliary cholangitis
    Kristel K. Leung, Maya Deeb, Gideon Morris Hirschfield · 2020 · Alimentary Pharmacology & Therapeutics
  24. Knockout of the primary sclerosing cholangitis‐risk gene Fut2 causes liver disease in mice
    Luca Maroni, Simon D. Hohenester, Stan F.J. van de Graaf, Dagmar Tolenaars, Krijn P. van Lienden, Joanne Verheij, Marco Marzioni, Tom H. Karlsen, Ronald P.J. Oude Elferink, Ulrich H. Beuers · 2017 · Hepatology
  25. Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases
    Vincent Zimmer, Frank Lammert · 2011 · Best Practice & Research Clinical Gastroenterology
  26. Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat
    Miriam Úriz, Elena Sáez, Jesús Prìeto, Juan F. Medina, Jesús M. Bañales · 2011 · PLoS ONE
  27. Role of AE2 for pHi regulation in biliary epithelial cells
    Axel R. Concepcion, María López, Alberto Ardura-Fabregat, Juan F. Medina · 2014 · Frontiers in Physiology
  28. S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis
    L. Reinhard, Christian Rupp, Hans-Dieter Riedel, Thomas Ruppert, Thomas Giese, Christa Flechtenmacher, Karl Heinz Weiss, Petra Kloeters-Plachky, Wolfgang Stremmel, Peter Schirmacher et al. · 2012 · PLoS ONE
  29. TGR5 Sequence Variation in Primary Sclerosing Cholangitis
    Johannes R. Hov, Verena Keitel, Erik Schrumpf, Dieter Häussinger, Tom H. Karlsen · 2011 · Digestive Diseases
  30. Role of the Anion Exchanger 2 in the Pathogenesis and Treatment of Primary Biliary Cirrhosis
    Juan F. Medina · 2011 · Digestive Diseases
  31. Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?
    Leonardo Baiocchi, Tianhao Zhou, Suthat Liangpunsakul, Ilaria Lenci, Francesco Santopaolo, Fanyin Meng, Lindsey Leann Kennedy, Shannon S. Glaser, Heather Francis, Gianfranco D. Alpini · 2019 · International Journal of Molecular Sciences
  32. Genome Editing for Cystic Fibrosis
    Guoshun Wang · 2023 · Cells
  33. Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach
    Hani S. Mousa, Marco Carbone, Federica Malinverno, Vincenzo Ronca, Merrill Eric Gershwin, Pietro Invernizzi · 2016 · Autoimmunity Reviews
  34. Regulation of bile secretion by calcium signaling in health and disease
    David C. Trampert, Michael H. Nathanson · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  35. Retrospective comparison of prednisolone and ursodeoxycholic acid for the treatment of feline lymphocytic cholangitis
    Corma MA Otte, Louis C. Penning, Jan Jaap Rothuizen, Robert P. Favier · 2012 · The Veterinary Journal
  36. Coordinated development of the mouse extrahepatic bile duct: Implications for neonatal susceptibility to biliary injury
    Gauri Khandekar, Jessica Llewellyn, Alyssa A. Kriegermeier, Orith Waisbourd‐Zinman, Nicolette Johnson, Yu Mei Du, Roquibat Giwa, Xiao Liu, Tatiana Kisseleva, Pierre Russo et al. · 2019 · Journal of Hepatology
  37. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review
    Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jin‐Jun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe‐Xiong Lian · 2020 · Clinical Reviews in Allergy & Immunology
  38. Pathophysiology and Clinical Management of Bile Acid Diarrhea
    Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Francesca Falangone, Davide Montanari, Federica Capuani, Giada Mastel, Vincenzo Stanghellini, Giovanni Barbara · 2022 · Journal of Clinical Medicine
  39. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b−/− mice favoring autoimmune cholangitis
    Axel R. Concepcion, January T. Salas, Elena Sáez, Sarai Sarvide, Alex Ferrer, Ainhoa Portu, Iker Uriarte, Sandra Hervás‐Stubbs, Ronald P.J. Oude Elferink, Jesús Prìeto et al. · 2015 · Oncotarget
  40. New Therapies on the Horizon for Primary Biliary Cholangitis
    Atsushi Tanaka · 2023 · Drugs
  41. The genetic architecture of primary biliary cholangitis
    Alessio Gerussi, Marco Carbone, Christophe Corpechot, Christoph Schramm, Rosanna Asselta, Pietro Invernizzi · 2021 · European Journal of Medical Genetics
  42. Current research on the treatment of primary sclerosing cholangitis
    Ahmad Hassan Ali, Elizabeth J. Carey, Keith D. Lindor · 2014 · Intractable & Rare Diseases Research
  43. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’
    Ulrich H. Beuers, Merrill Eric Gershwin, Robert Gareth Gish, Pietro Invernizzi, David E. Jones, Keith D. Lindor, Xiong Ma, Ian R Mackay, Albert Rodrigo Parés, Atsushi Tanaka et al. · 2015 · Gut
  44. Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury
    Nan Wu, Leonardo Baiocchi, Tianhao Zhou, Lindsey Leann Kennedy, Ludovica Ceci, Fanyin Meng, Keisaku Sato, Chaodong Wu, Burcin Ekser, Konstantina Kyritsi et al. · 2020 · Hepatology
  45. Biliary Bicarbonate Secretion Constitutes a Protective Mechanism against Bile Acid- Induced Injury in Man
    Simon D. Hohenester, Lucas J. Maillette de Buy Wenniger, Douglas M. Jefferson, Ronald P.J. Oude Elferink, Ulrich H. Beuers · 2011 · Digestive Diseases
  46. New treatments/targets for primary biliary cholangitis
    Christophe Corpechot, Raoul Y. Poupon, Olivier Chazouillères · 2019 · JHEP Reports
  47. New Therapeutic Targets in Autoimmune Cholangiopathies
    Alessio Gerussi, Martina De Luca, Laura Cristoferi, Vincenzo Ronca, Clara Mancuso, Chiara Milani, Daphne D’Amato, Sarah Elizabeth O'Donnell, Marco Carbone, Pietro Invernizzi · 2020 · Frontiers in Medicine
  48. Current Treatment Options for Cystic Fibrosis-Related Liver Disease
    Katharina Staufer · 2020 · International Journal of Molecular Sciences
  49. Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells
    Justyna Magdalena Kowal, Kristian Agmund Haanes, Nynne M. Christensen, Ivana Novak · 2015 · Cell Communication and Signaling
  50. Unmet Challenges in Immune-Mediated Hepatobiliary Diseases
    Ulrich H. Beuers, Merrill Eric Gershwin · 2015 · Clinical Reviews in Allergy & Immunology
  51. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
    Ulrich H. Beuers, Merrill Eric Gershwin, Robert Gareth Gish, Pietro Invernizzi, David E. Jones, Keith D. Lindor, Xiong Ma, Ian R. Mackay, Albert Rodrigo Parés, Atsushi Tanaka et al. · 2015 · Clinical Gastroenterology and Hepatology
  52. Primary sclerosing cholangitis: review for radiologists
    Matthew A. Morgan, Rachita Khot, Karthik M. Sundaram, Daniel R. Ludwig, Rashmi T Nair, Pardeep Mittal, Dhakshinamoorthy Ganeshan, Sudhakar Kundapur Venkatesh · 2022 · Abdominal Radiology
  53. Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
    Michael Trauner, Saul J. Karpen, Paul A. Dawson · 2025 · Hepatology
  54. Genetics in primary sclerosing cholangitis
    Trine Folseraas, Espen Melum, André Franke, Tom H. Karlsen · 2011 · Best Practice & Research Clinical Gastroenterology
  55. Tissue engineering of the biliary tract and modelling of cholestatic disorders
    Teresa Brevini, Olivia Tysoe, Fotios Sampaziotis · 2020 · Journal of Hepatology
  56. TNAP: A New Multitask Enzyme in Energy Metabolism
    Anne Briolay, Laurence Bessueille, David Magne · 2021 · International Journal of Molecular Sciences
  57. Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis
    Jung‐Chin Chang, Simei Go, Arthur J. Verhoeven, Ulrich H. Beuers, Ronald P.J. Oude Elferink · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  58. Viability Assessment During Normothermic Machine Liver Perfusion: A Literature Review
    Heithem Jeddou, Stylianos Tzedakis, Mohamed Ali Chaouch, Laurent Sulpice, Michel Samson, Karim Boudjéma · 2025 · Liver International
  59. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection
    Herta, Toni, Kersten, Remco, Chang, Jung-Chin, Hubers, Lowiek, Go, Simei, Tolenaars, Dagmar, Paulusma, Coen C., Nathanson, Michael H., Elferink, Ronald Oude, van de Graaf, Stan F.J. et al. · 2022 · Journal of Hepatology
  60. Progress in research on the roles of TGR5 receptor in liver diseases
    Ke Ma, Dan Tang, Chang Jiang Yu, Lijin Zhao · 2021 · Scandinavian Journal of Gastroenterology
  61. Post-COVID-19 Cholangiopathy: A Systematic Review
    Beshoy Yanny, Mohammed Alkhero, Mohammed Alani, Daniel Stenberg, Aryan Saharan, Sammy Saab · 2022 · Journal of Clinical and Experimental Hepatology
  62. Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP 1B1, OATP 1B3, OATP 2B1 and NTCP
    Jörg König, Sabine Klatt, Karin Dilger, Martin F. Fromm · 2012 · Basic & Clinical Pharmacology & Toxicology
  63. An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer’s disease and neurodegeneration
    Adrianne F. Pike, Nynke I. Kramer, Bas J. Blaauboer, Willem Seinen, Ruud Brands · 2014 · Chemico-Biological Interactions
  64. Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma
    Margriet R. Timmer, Ulrich H. Beuers, Paul Fockens, Cyriel Y. Ponsioen, Erik A. Rauws, Kenneth K. Wang, Kausilia Krishnawatie Krishnadath · 2013 · Inflammatory Bowel Diseases
  65. Genetic variations of bile salt transporters
    Ralf Kubitz, Carola Dröge, Stefanie Kluge, Jan Stindt, Dieter Häussinger · 2014 · Drug Discovery Today Technologies
  66. Promoter hypermethylation of the AE2/SLC4A2 gene in PBC
    Fabián Arenas, Isabel Hervías, Elena Sáez, Saida Melero, Jesús Prìeto, Albert Rodrigo Parés, Juan Francisco Medina · 2019 · JHEP Reports
  67. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts
    Burcin Özdirik, Bernd Schnabl · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  68. Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease
    Laurent Ehrlich, Marinda Scrushy, Fanyin Meng, Terry C. Lairmore, Gianfranco D. Alpini, Shannon S. Glaser · 2018 · Clinics and Research in Hepatology and Gastroenterology
  69. Pathophysiology and Imaging Findings of Bile Duct Necrosis: A Rare but Serious Complication of Transarterial Therapy for Liver Tumors
    Satoshi Kobayashi, Kazuto Kozaka, Toshifumi Gabata, Osamu Matsui, Wataru Koda, Miho Okuda, Kenichiro Okumura, Takumi Sugiura, Takahiro Ogi · 2020 · Cancers
  70. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’
    Ulrich H. Beuers, Merrill Eric Gershwin, Robert Gareth Gish, Pietro Invernizzi, David E. Jones, Keith D. Lindor, Xiong Ma, Ian R. Mackay, Albert Rodrigo Parés, Atsushi Tanaka et al. · 2015 · Digestive and Liver Disease
  71. Genetics in liver disease: new concepts
    Vincent Zimmer, Frank Lammert · 2011 · Current Opinion in Gastroenterology
  72. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis
    Francesca Saffioti, Vasileios K. Mavroeidis · 2021 · World Journal of Gastrointestinal Oncology
  73. The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
    Ronca, Vincenzo, Davies, Scott P., Oo, Ye Htun, Lleo, Ana · 2025 · Hepatology
  74. Bile Acids—A Peek Into Their History and Signaling
    James ThienToan Nguyen, Ryan Philip Henry Shaw, Sayeepriyadarshini Anakk · 2022 · Endocrinology
  75. Genetics in primary sclerosing cholangitis
    Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, André Franke, Tom H. Karlsen · 2012 · Clinics and Research in Hepatology and Gastroenterology
  76. Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia
    David C. Trampert, Stan F.J. van de Graaf, Aldo Jongejan, Ronald P.J. Oude Elferink, Ulrich H. Beuers · 2020 · Journal of Hepatology
  77. Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies
    Michael Trauner, Emina Halilbasic, Lili Kazemi-Shirazi, Christian Kienbacher, Katharina Staufer, Stefan Traussnigg, Harald Hofer · 2014 · Digestive Diseases
  78. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis
    Jennifer A. Scott, Andrew M. Jones, Karen Piper Hanley, Varinder Singh Athwal · 2022 · Alimentary Pharmacology & Therapeutics
  79. Cholic Acid Induces a Cftr Dependent Biliary Secretion and Liver Growth Response in Mice
    Frank A.J.A. Bodewes, Marcel J. C. Bijvelds, Willemien de Vries, J Baller, Annette Gouw, Hugo R. de Jonge, Henkjan J. Verkade · 2015 · PLoS ONE
  80. Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
    Antonio Molinaro, Hanns–Ulrich Marschall · 2017 · Current Hepatology Reports
  81. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies
    Kari Nichole Nejak‐Bowen · 2019 · Gene Expression
  82. Magnitude of acute respiratory infections in under five.
    P Chhabra, S Garg, Sankalp Mittal, L Satyanarayan, Mandeep R. Mehra, N Sharma · 1993 · PubMed
  83. Effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience
    Pier Luigi Calvo, Laura Giugliano, Andrea Evangelista, Elisabetta Bignamini, Michele Pinon · 2023 · Journal of Hepatology
  84. From pathogenesis to novel therapies in the treatment of primary biliary cholangitis
    Vincenzo Ronca, Marco Carbone, Francesca Bernuzzi, Federica Malinverno, Hani S. Mousa, M. Eric Gershwin, Pietro Invernizzi · 2017 · Expert Review of Clinical Immunology
  85. Bile Biochemistry Following Liver Reperfusion in the Recipient and Its Association With Cholangiopathy
    Rohit Gaurav, Niroshan Atulugama, Lisa Swift, Andrew J. Butler, Sara S. Upponi, Rebecca J. Brais, Michael Allison, Christopher J.E. Watson · 2020 · Liver Transplantation
  86. Current Therapeutics in Primary Sclerosing Cholangitis
    Natassia Tan, John Samuel Lubel, William W. Kemp, Stuart Keith Roberts, Ammar Majeed · 2023 · Journal of Clinical and Translational Hepatology
  87. Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD)
    Swati Singh, Anit Kumar, Suruchi Gupta, Rohini Agrawal · 2023 · Tissue Barriers
  88. Emerging drugs for the treatment of Primary Biliary Cholangitis
    Ahmad Hassan Ali, James H. Tabibian, Elizabeth J. Carey, Keith D. Lindor · 2016 · Expert Opinion on Emerging Drugs
  89. Obeticholic acid for the treatment of primary biliary cirrhosis
    David E. Jones · 2016 · Expert Review of Gastroenterology & Hepatology
  90. Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): A hypothesis
    Neil David Theise, James M. Crawford, Yasuni Nakanuma, Alberto Quaglia · 2020 · Medical Hypotheses
  91. Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
    Fangling Zhang, Xiaolin Xiao, Yong Li, Hefei Wu, Xinyu Deng, Yinxiao Jiang, Wenwen Zhang, Jian Wang, Xiao Ma, Yanling Zhao · 2022 · Frontiers in Pharmacology
  92. Bile formation in long-term ex situ perfused livers
    Dilmurodjon Eshmuminov, Martin J. Schuler, Dustin Becker, Lucía Bautista Borrego, Matteo Mueller, Catherine Hagedorn, Stéphanie Häusler, Julia Steiger, Mark W. Tibbitt, Philipp Dutkowski et al. · 2021 · Surgery
  93. Ursodeoxycholic Acid in Intrahepatic Cholestasis of Pregnancy: A Systematic Review and Individual Participant Data Meta-analysis
    Caroline Ovadia, Jenna Sajous, Paul Townsend Seed, Kajol Patel, Nicholas J Williamson, George Attilakos, Francesco Azzaroli, Yannick Bacq, Linoy Batsry, Kelsey Broom et al. · 2021 · Obstetrical & Gynecological Survey
  94. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects
    Claudia Daniela Fuchs, Emmanuel Dauda Dixon, Tim Hendrikx, Veronika Mlitz, Annika M. Wahlstrom, Marcus Ståhlman, Hubert Scharnagl, Tatjana Stojaković, Christoph J. Binder, Hanns–Ulrich Marschall et al. · 2022 · Hepatology Communications
  95. Physiology of Cholangiocytes
    Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso · 2012 · Elsevier eBooks
  96. Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
    Jian V. Huang, Giordano Sigon, Benjamin Harvey Mullish, Dan Wang, Rohini Sharma, Pinelopi Manousou, Roberta Forlano · 2023 · Nutrients
  97. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches
    Michele Pinon, Binita Maya Kamath · 2024 · Current Opinion in Pediatrics
  98. Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation
    Yanik J. Bababekov, Anna H. Ha, Trevor L. Nydam, Carlos Goncalves, Rashikh A. Choudhury, JoLynn Shinsako, Maria R. Baimas‐George, David M. Reynolds, Cassidy Yoshida, Caroline A. Racke et al. · 2025 · Transplantation Direct
  99. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies
    Motoko Sasaki, Yasuni Nakanuma · 2016 · Clinics and Research in Hepatology and Gastroenterology
  100. Impact of hypoxia and AMPK on CFTR-mediated bicarbonate secretion in human cholangiocyte organoids
    Floris J.M. Roos, Marcel J. C. Bijvelds, Monique M. A. Verstegen, Henk P. Roest, Herold Johnny Metselaar, Wojciech Grzegorz Polak, Hugo R. de Jonge, Jan N.M. IJzermans, Luc J. W. van der Laan · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology